Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Fifth Circuit Mifepristone Ruling May Temporarily Halt Pharmacy Dispensing, Generic Approval

Apr 13 2023

• By Brenda Sandburg

FDA and pill — Fifth Circuit retains FDA's 2000 approval of mifepristone medicatoin abortion pill • Source: Shutterstock

Related Content

Biopharma Companies – But Not PhRMA – Argue That Mifepristone Ruling ‘Radically Alters’ NDA Process

Apr 13 2023

What’s Next For FDA In Face Of Opposing Mifepristone Injunctions

Apr 09 2023

Abortion Pill Mifepristone Will No Longer Require In-Person Pick Up, US FDA Concludes

Dec 17 2021

Additional Topics

United States FDA Drug Approval Standards Legal Issues Market Access Regulation Women's Health Politics BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window